RHEOS MEDICINES, INC.

Profile

Company Names

RHEOS MEDICINES, INC.

Addresses

38 SIDNEY STREET, SUITE 200, CAMBRIDGE, MA 02139

Phone Numbers

857-777-4242

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$27,500,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-03-20 
$27,500,000.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
 
BLUESTONE 
DIRECTOR
RHEOS MEDICINES, INC.   |  SONOMA BIOTHERAPEUTICS, INC.
ABBIE 
 
CELNIKER 
EXECUTIVE OFFICER, DIRECTOR
TALIGEN THERAPEUTICS INC   |  IMAGINAB, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  GOLDFINCH BIOPHARMA, INC.   |  RHEOS MEDICINES, INC.   |  PANOPTICA, INC.   |  THIRD ROCK VENTURES V, L.P.   |  GOLDFINCH BIO, INC.   |  CEDILLA THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.
RYAN 
 
COHLHEPP 
EXECUTIVE OFFICER
RHEOS MEDICINES, INC.
J. DUNCAN 
 
HIGGONS 
DIRECTOR
RHEOS MEDICINES, INC.
SANJAY 
 
KESWANI 
EXECUTIVE OFFICER, DIRECTOR
RHEOS MEDICINES, INC.   |  ANNEXON, INC.
DAN 
 
MATLOFF 
EXECUTIVE OFFICER
RHEOS MEDICINES, INC.   |  IMMUNITAS THERAPEUTICS, INC.
CARY 
 
PFEFFER 
DIRECTOR
ELEVEN BIOTHERAPEUTICS, INC.   |  TARIS BIOMEDICAL INC   |  EDIMER PHARMACEUTICALS, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  RHEOS MEDICINES, INC.   |  THIRD ROCK VENTURES V, L.P.   |  JOUNCE THERAPEUTICS, INC.   |  FAZE MEDICINES, INC.   |  THIRD ROCK VENTURES VI, L.P.
STEPHEN 
 
SHERWIN 
DIRECTOR
NEON THERAPEUTICS, INC.   |  RHEOS MEDICINES, INC.
GAD 
 
SOFFER 
EXECUTIVE OFFICER
SANTA MARIA BIOTHERAPEUTICS, INC.   |  PINTA BIOTHERAPEUTICS, INC.   |  NINA BIOTHERAPEUTICS, INC.   |  RHEOS MEDICINES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-11-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-20 
2018-10-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-20 
2018-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#